HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hiroyuki Kobori Selected Research

nitrosonifedipine

1/2014Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hiroyuki Kobori Research Topics

Disease

52Hypertension (High Blood Pressure)
12/2015 - 02/2002
15Diabetic Nephropathies (Diabetic Nephropathy)
12/2015 - 05/2006
12Kidney Diseases (Kidney Disease)
12/2014 - 05/2006
11Proteinuria
01/2014 - 03/2005
10Albuminuria
12/2015 - 09/2008
9IGA Glomerulonephritis (IGA Nephropathy)
06/2015 - 05/2006
6Fibrosis (Cirrhosis)
03/2013 - 09/2009
5Inflammation
06/2015 - 01/2008
4Glomerulonephritis
06/2015 - 01/2010
3Vascular System Injuries
01/2014 - 04/2003
3Wounds and Injuries (Trauma)
01/2014 - 01/2013
3Body Weight (Weight, Body)
04/2012 - 09/2008
3Hypertrophy
10/2011 - 01/2008
3Nephritis
03/2011 - 05/2008
2Insulin Resistance
11/2013 - 01/2007
2Type 2 Diabetes Mellitus (MODY)
02/2013 - 05/2012
2Obesity
04/2012 - 09/2010
2Renal Hypertension
01/2012 - 06/2011
1Glycosuria
12/2015
1Hyperkalemia
12/2015
1Hypotension (Low Blood Pressure)
12/2015
1Neoplasms (Cancer)
01/2015
1Adenocarcinoma
01/2015
1Hypoglycemia (Reactive Hypoglycemia)
09/2014
1Hyperglycemia
01/2014
1Glucose Intolerance
11/2013
1Hyperlipidemias (Hyperlipidemia)
11/2013
1Diabetes Mellitus
02/2013
1Necrosis
10/2012
1Cardiovascular Diseases (Cardiovascular Disease)
04/2012
1Aortic Valve Insufficiency (Aortic Regurgitation)
03/2012
1Heart Failure
03/2012
1Tachycardia (Tachyarrhythmias)
11/2011
1Malignant Hyperthermia
11/2011
1Arteriosclerosis
10/2011

Drug/Important Bio-Agent (IBA)

47AngiotensinogenIBA
06/2015 - 02/2002
28Angiotensin IIIBA
09/2014 - 02/2002
15ReninIBA
01/2015 - 02/2002
13SodiumIBA
12/2015 - 03/2003
11Messenger RNA (mRNA)IBA
10/2014 - 04/2003
10AngiotensinsIBA
06/2013 - 01/2003
8Glucose (Dextrose)FDA LinkGeneric
12/2015 - 03/2005
8olmesartanIBA
03/2013 - 07/2004
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 - 10/2003
6Immunoglobulin A (IgA)IBA
01/2011 - 05/2006
5CreatinineIBA
12/2015 - 09/2008
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2013 - 02/2009
5Hydralazine (Apresoline)FDA LinkGeneric
03/2012 - 03/2004
4Type 1 Angiotensin ReceptorIBA
09/2014 - 09/2008
4AldosteroneIBA
09/2014 - 03/2012
4Angiotensin II Type 1 Receptor BlockersIBA
01/2013 - 09/2008
4eplerenone (Inspra)FDA LinkGeneric
03/2012 - 03/2010
3Transforming Growth Factors (Transforming Growth Factor)IBA
10/2014 - 09/2009
3NADPH Oxidase (NAD(P)H oxidase)IBA
01/2014 - 01/2012
3Superoxides (Superoxide)IBA
01/2014 - 03/2004
3tempolIBA
01/2012 - 03/2004
2Spironolactone (Aldactone)FDA LinkGeneric
12/2015 - 11/2013
2Small Interfering RNA (siRNA)IBA
01/2015 - 06/2012
2aliskirenFDA Link
10/2014 - 01/2012
2Insulin (Novolin)FDA Link
09/2014 - 10/2011
2Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2014 - 03/2012
2Chymases (Chymase)IBA
02/2013 - 09/2009
2Antihypertensive Agents (Antihypertensives)IBA
01/2013 - 09/2007
2CytokinesIBA
10/2012 - 05/2012
2DesminIBA
05/2012 - 11/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012 - 10/2010
2valsartan (Vals)FDA Link
01/2012 - 01/2011
2CollagenIBA
01/2012 - 03/2011
2Carbon MonoxideIBA
11/2011 - 05/2010
2Phosphotransferases (Kinase)IBA
10/2011 - 11/2010
2salicylhydroxamic acid (SHAM)IBA
06/2011 - 01/2003
2Purinergic P2 Receptors (ADP Receptor)IBA
06/2011 - 01/2008
2telmisartan (Micardis)FDA Link
03/2010 - 09/2008
1cyclonite (RDX)IBA
12/2015
1IronIBA
06/2015
1vildagliptinIBA
04/2015
1Glucagon-Like Peptide 1 (GLP 1)IBA
04/2015
1Plasminogen Activators (Plasminogen Activator)IBA
10/2014
1Sodium-Hydrogen AntiporterIBA
09/2014
1rho-Associated KinasesIBA
03/2014
1nitrosonifedipineIBA
01/2014
1Calcium Channels (Calcium Channel)IBA
01/2014
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2014
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2014
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
11/2013
1FructoseIBA
11/2013
1Epithelial Sodium ChannelIBA
06/2013
1temocapril hydrochloride (temocapril)IBA
01/2013
1InterferonsIBA
05/2012
1Interleukin-6 (Interleukin 6)IBA
05/2012
1AdipokinesIBA
04/2012
1Peroxynitrous Acid (Peroxynitrite)IBA
01/2012
1Leucine (L-Leucine)FDA Link
10/2011
1anthra(1,9-cd)pyrazol-6(2H)-oneIBA
10/2011
1ebselenIBA
10/2011
1SB 203580IBA
10/2011

Therapy/Procedure

2Sympathectomy (Sympathectomies)
12/2015 - 03/2012
2Sodium-Restricted Diet (Diet, Sodium Restricted)
03/2013 - 08/2011
1Denervation
03/2012
1General Anesthesia
11/2011